Disclaimer: This is a free English translation of the PR issued in French, only provided for the convenience of English reader

PRESS RELEASE

First papers published by French researchers given free access to

THIN, the real-life medico-economic databasemanaged by GERS Data

Boulogne-Billancourt, July 11, 2018

GERS Datais a Cegedim Group subsidiary and a key healthcare market data and analysis player in France. The company is pleased to announce that the first papers by research physicians given free access(1)to real-life data(2)from theTHINdatabase have been published.

One group of physicians focused on the "Analysis of diagnostic strategies forSjogren's syndrome in France in primarycare clinics using an electronic health database(3)".Their work was presented at the 76thFranco-Maghreb InternalMedicine Conference. Another group dealt with "Assessing monitoring of recommendations for treating urinary infections in primary care clinics in France(4)". The second group presented their resultsin June at the French Infectious DiseaseSociety's 19thannual conference in Nantes.

THINis the new name for GERS Data's real-life database

GERS Dataisnow marketing the database created from Cegedim's medical software in France and the UK under thenameTHIN (The Health Improvement Network). The database uses a big data format that can be accessed using AI techniques. The UK version ofTHINhas been used in over 600 research papers worldwide and is well known in international medical research circles.

TheTHINdatabase complies with all current data protection laws (GDPR) and adheres to the Observational Medical Outcomes Partnership (OMOP) model. That means it is compatible with most existing international data sources. Researchers usingTHINcan extract a targeted, accurate set of medical and economic data on course of care from both private practices and hospitals.

The real-life data are hosted on servers certified to host personal health records and are available virtually in real time. The data can be accessed as anonymized data or with big data technologies using secure SaaS protocols. They meet all standards for quality, representative data for performing real-world research, particularly the requirements for conducting retrospective studies.

Researchers given free access to THIN, the first Franco-British real-life database(1)

GERS Dataunderstands the difficulties "unsponsored(2)"French researchers have had gaining access to real-life medico-economic data. The company is now giving those researchers free access to its data, requiring only a quick, simplified application process.

"We are proud to see thefirst results from French researchersto whom we've givenfree access to the GERS Data real-life medico-economic data. I want to sincerely thank all of the physicians who worked on this project, as well as Professor Jean-François Bergmann and his colleagues, who volunteered their time to make it all work,"saidJean-Claude Labrune, Cegedim Chairman and CEO."There are more papers on the way. Some of them deal with rarediseases for which in-depth patient histories are vital, because years often go by between the first doctor visit andthe diagnosis," he added.

  • 1Anonymized data comply with all current laws.

  • 2Notably as part of unsponsored research programs.

  • 3Mangin, O.; Lekens, B.; Mouly, S.; Bergmann, J.F. and Sene, D."Analyse des stratégies de diagnostic du syndrome de Gougerot Sjögren en France enmédecine de ville à partir d'une base de données de santé électronique". La Revue de Médecine Interne. December 2017, V38, S2: A91-A92.

4Iordache, L.; Strazzula, A.; Lekens, B.; Bergmann, J.F. and Diamantis, S."Évaluation du suivi des recommandations de prise en charge des infections urinaires en médecine de ville en France". Médecine et Maladies Infectieuses. June 2018, V48, I4: S101-S102.

Cegedim

137 rue d'Aguesseau, 92100 Boulogne-Billancourt

Tél. : +33 (0)1 49 09 22 00

www.cegedim.fr

SA au capital de 13 336 506,43 euros SIREN 350 422 622

R. C. S. Nanterre B 350 422 622

Page 1

PRESS RELEASE

About GERS Data:

For more than 40 years,GERS Datahas offered data and analyses for the healthcare market from a single data collection system. The offer to cover the different healthcare professionals and the distribution channel for general practitioners and hospitals. The data range (Purchases & Sales) the geographic accuracy, France to the point of sale as well as modern visualization solutions meeting the needs of the players in the self-medication drugs, food supplements, medical and dermo-cosmetic devices. The reliability and accuracy of its data have madeGERS Datahighly recommended with the health authorities and unions.

About Cegedim:

Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 4,200 people inmore than 10 countries and generated revenue of €457 million in 2017. Cegedim SA is listed in Paris (EURONEXT: CGM).

To learn more, please visit:www.cegedim.com

And follow Cegedim on Twitter:@CegedimGroup,LinkedInandFacebook

Aude BalleydierCegedim

Gilles PaubertGERS Data

Media Relations and Communications Manager

Global Head of Real World Data

Tel.: +33 (0)1 49 09 68 81aude.balleydier@cegedim.com

Tel : +33 (0)1 49 09 67 07gilles.paubert@cegedim.fr

Marina RosoffFor Madis PhileoFollow Cegedim:

Media Relations

Tel: +33 (0)6 71 58 00 34marina@madisphileo.com

Page 2

Attachments

  • Original document
  • Permalink

Disclaimer

Cegedim SA published this content on 13 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 July 2018 09:59:02 UTC